5 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Assessment of the Safety and Efficacy of Balstilimab in Combination With Botensilimab for the Treatment of Non-Small Cell Lung Cancer (IMMONC0008)Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasmActive, not recruitingPhase 22026-06-08NCT06322108
Assessment of the Safety and Efficacy of Balstilimab for the Treatment of Relapsed/Refractory Lymphomas (IMMONC0001)Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasmRecruitingPhase 22026-06-08NCT05891821
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) International RegistryCD4+/CD56+ hematodermic neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Skin and Connective Tissue Diseases, hematologic disorder, hematopoietic and lymphoid system neoplasm, leukemia, lymphoma, malignant histiocytosis, neoplasm, skin disorder, skin neoplasmRecruitingNot stated2026-06-05NCT05430971
Cardiac Angiosarcoma International RegistryNeoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, angiosarcoma, neoplasm, sarcoma, vascular cancerRecruitingNot stated2026-02-18NCT06715579
Rare Embryonal Tumors of the Central Nervous System: International RegistryNeoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, embryonal neoplasm, neoplasmRecruitingNot stated2025-05-08NCT05711992